Beta Bionics, J.B. Hunt Transport And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
U.S. stock futures rose, but Beta Bionics fell 7.1% after pricing a stock offering; several other stocks also declined in premarket trading.
Stocks · News reference
US stock futures mixed, Nasdaq up 0.1%. Mercury Systems Inc down 10.6%, other stocks also falling. Companies report mixed quarterly results.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
U.S. stock futures rose, but Beta Bionics fell 7.1% after pricing a stock offering; several other stocks also declined in premarket trading.
Healthcare stocks UTHR, COLL and AHG show oversold RSI levels near or below 30, potentially offering undervalued buying opportunities.
Dow Jones down 300 points, Deere & Co shares up 7.9% after beating earnings expectations. SCTX, SCSC, BTBT, MRVI, HIVE, AHG, TEM, MARA, LB also gain.
Kaplan Fox has filed securities class action lawsuits against three companies: Cogent Communications for allegedly misrepresenting demand and backlog for optical wavelengths (Class Period: Feb 29, 2024 - May 1, 2026), Hims & Hers Health (Class Period: Aug 4, 2025 - July 29, 2026), and EquipmentShare.Com related to its January 2026 IPO. Investors have until September 21, 2026 to seek lead plaintiff status in the Cogent and EquipmentShare cases, and November 2, 2026 for Hims & Hers.
The article explores how stocks with rising P/E ratios paired with accelerating earnings growth can deliver strong returns. Using specific screening criteria focused on earnings momentum and price performance, the analysis identifies four stocks: H World Group Limited (HTHT), Inovio Pharmaceuticals (INO), Nouveau Monde Graphite (NMG), and Cogent Communications (CCOI) as potential outperformers with consistent price gains and strong earnings surprises.
A securities class action lawsuit has been filed against Cogent Communications Holdings, Inc. (CCOI) for allegedly making false statements about its optical wavelength business backlog and financial capacity. The complaint alleges the company misrepresented customer demand and failed to disclose that most backlog orders were unlikely to convert to paid orders. CCOI's stock has declined over 80% from its Class Period high, with major drops following dividend cuts and weak financial disclosures. Investors have until September 21, 2026, to seek lead plaintiff appointment.